Invention Grant
- Patent Title: Antipsychotic treatment based on SNP genotype
-
Application No.: US12675598Application Date: 2008-09-10
-
Publication No.: US09328387B2Publication Date: 2016-05-03
- Inventor: Christian Lavedan , Simona Volpi , Louis Licamele , Mihael H. Polymeropoulos
- Applicant: Christian Lavedan , Simona Volpi , Louis Licamele , Mihael H. Polymeropoulos
- Applicant Address: US DC Washington
- Assignee: Vanda Pharmaceuticals, Inc.
- Current Assignee: Vanda Pharmaceuticals, Inc.
- Current Assignee Address: US DC Washington
- Agency: Hoffman Warnick LLC
- International Application: PCT/US2008/075845 WO 20080910
- International Announcement: WO2009/036056 WO 20090319
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12P19/34
Abstract:
The present invention relates to the prediction of antipsychotic treatment efficacy based on a patient's genotype at one or more single nucleotide polymorphism (SNP) loci and to the treatment of a patient based on such prediction.
Public/Granted literature
- US20100292211A1 ANTIPSYCHOTIC TREATMENT BASED ON SNP GENOTYPE Public/Granted day:2010-11-18
Information query
